Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03688672 · ClinicalTrials.gov registry record · NA
Apioc Contact Lens Feasibility
A NA study of Myopia and Presbyopia, sponsored by Lentechs.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT03688672: Completed NA study of Myopia and Presbyopia, sponsored by Lentechs.
NCT03688672 is a NA study of Myopia and Presbyopia that has completed, run by Lentechs. The registered enrollment target is 50 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03688672, a NA study of Myopia and Presbyopia, has completed, sponsored by Lentechs.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial will document the feasibility of the Apioc lens design by assessing which lens shape parameters yield successful on-eye-fit and movement of the Apioc contact lens design and evaluate the subjectively-reported comfort of the Apioc contact lens design.
Primary Outcome
Vertical movement of the contact lens relative to the eye in downgaze in millimeters.
Conditions Studied
Interventions
- DEVICE Apioc Contact Lens Design
Study Locations (1)
Ohio
- The Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2018-10-01 |
| Est. Completion | 2020-10-31 |
| Phase | NA |
What the finished NCT03688672 record still lists
NCT03688672 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (81% lower).
The record links to 5 conditions, with Myopia appearing as the primary indexed condition, and to 1 intervention - of which Apioc Contact Lens Design is the first listed.
NCT03688672 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT03688672 about?
NCT03688672 is a clinical study titled "Apioc Contact Lens Feasibility". This clinical trial will document the feasibility of the Apioc lens design by assessing which lens shape parameters yield successful on-eye-fit and movement of the Apioc contact lens design and evaluate the subjectively-reported comfort of the Apioc contact lens design.
What is the current status of trial NCT03688672?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2018-10-01. Estimated completion is 2020-10-31.
What conditions does trial NCT03688672 study?
This clinical trial studies the following conditions: Myopia, Presbyopia, Astigmatism, Hyperopia, Ametropia.
What interventions are being tested in trial NCT03688672?
The interventions under investigation include: Apioc Contact Lens Design (DEVICE).
Who is sponsoring clinical trial NCT03688672?
This trial is sponsored by Lentechs, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03688672 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03688672's enrollment target sits among peer trials
50 70th of 90 higher than 16 of 90 other Myopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
RECRUITING · NA
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
Children's Viewing Behavior
RECRUITING · NA
-
Violet Light for the Suppression of Myopia
RECRUITING · NA
-
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
RECRUITING · NA
-
Wavelength Intervention for Nearsighted Kids
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI